Clinical Trials
38 trialsNCT05726292 2026-03-04
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
University of Chicago
Phase 2 Recruiting
NCT01410942 2026-02-20
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01489813 2025-02-05
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Emory University
Phase 2 Completed
NCT06468254 2024-06-21
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
Anhui Provincial Cancer Hospital
Phase 2 Recruiting
NCT00204490 2024-05-16
Soy Isoflavones and Breast Cancer Risk Reduction
The University of Texas Medical Branch, Galveston
Phase 2 Completed
NCT02523898 2024-04-25
Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant
Semnan University of Medical Sciences
Phase 2 Terminated
NCT01353209 2024-04-17
TRAIL
University of Cincinnati
Phase 2 Completed
NCT04899921 2024-03-26
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT02440464 2023-01-04
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 2 Completed
NCT02055963 2022-10-20
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03549650 2022-03-04
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Terminated
NCT01988571 2022-01-04
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Wake Forest University Health Sciences
Phase 2 Completed
NCT01793051 2021-11-24
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02137252 2021-11-16
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT01173692 2021-08-20
Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01238120 2021-05-05
The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients
University of Rochester
Phase 2 Completed
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01636934 2020-07-17
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01693523 2020-03-09
Minocycline Study in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02285855 2020-01-06
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01443026 2019-11-19
The Effects of Lycopene on High Risk Prostatic Tissue
University of Illinois at Chicago
Phase 2 Completed
NCT02301897 2019-06-19
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Completed
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated
NCT02767752 2018-07-10
CHIPAC
Herlev Hospital
Phase 2 Terminated
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01797120 2018-05-30
PrE0102
PrECOG, LLC.
Phase 2 Completed
NCT02166346 2018-04-17
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
Johns Hopkins University
Phase 2 Completed
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01733953 2016-12-14
Statin Therapy in Young Adult Survivors of Childhood Cancer
University of Minnesota
Phase 2 Completed
NCT02041325 2016-05-17
Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias
Boston VA Research Institute, Inc.
Phase 2 Completed
NCT00917735 2016-02-22
Green Tea and Reduction of Breast Cancer Risk
University of Minnesota
Phase 2 Completed
NCT00178373 2015-12-23
Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer
University of Rochester
Phase 2 Completed
NCT00529542 2014-09-25
A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol
Milton S. Hershey Medical Center
Phase 2 Completed
NCT00493636 2014-05-20
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
Accelerated Community Oncology Research Network
Phase 2 Completed
NCT01427205 2013-04-05
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00522197 2012-03-09
ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia
British Columbia Cancer Agency
Phase 2 Completed
NCT00454181 2011-09-16
Treatment of Oral Warts in HIV+ Patients
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Phase 2 Completed
NCT00080743 2009-08-06
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
Dartmouth-Hitchcock Medical Center
Phase 2 Completed